Institutional Ownership Aclaris Therapeutics, Inc. (ACRS)
This table provides information about the institutional ownership of Aclaris Therapeutics, Inc. (ACRS). We have compiled data on the 98 institutions that hold shares in the stock, with a total of 87.6 Million shares, which have been reported (via 13F filing form) to have a value of $144 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bml Capital Management, LLC
Zionsville, IN |
Aug 11, 2025 Q2 2025 |
14,250,000
shares
|
$23.4 Million
15.31% of portfolio
|
Q3 2024
Added 9.72%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
9,627,304
shares
|
$15.8 Million
0.02% of portfolio
|
Q4 2024
New holding
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
8,888,888
shares
|
$14.6 Million
2.67% of portfolio
|
Q4 2024
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
6,662,063
shares
|
$10.9 Million
0.0% of portfolio
|
Q2 2025
Added 34.04%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
4,769,309
shares
|
$7.82 Million
0.46% of portfolio
|
Q2 2025
Reduced 5.49%
|
|
Decheng Capital LLC
Menlo Park, CA |
Aug 13, 2025 Q2 2025 |
4,041,736
shares
|
$6.63 Million
1.45% of portfolio
|
Q1 2025
Added 78.31%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
3,837,380
shares
|
$6.29 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.18%
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
3,540,192
shares
|
$5.81 Million
0.0% of portfolio
|
Q2 2025
Added 46.56%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
2,800,282
shares
|
$4.59 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.9%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,464,779
shares
|
$4.04 Million
0.0% of portfolio
|
Q2 2025
Added 108.4%
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
2,433,850
shares
|
$3.99 Million
0.01% of portfolio
|
Q2 2025
Added 10.87%
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
2,292,449
shares
|
$3.76 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.89%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,032,155
shares
|
$3.33 Million
0.0% of portfolio
|
Q2 2024
Reduced 60.94%
|
|
Logos Global Management LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,850,000
shares
|
$3.03 Million
0.34% of portfolio
|
Q2 2025
Reduced 16.75%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,464,778
shares
|
$2.4 Million
0.0% of portfolio
|
Q2 2025
Added 53.96%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Aug 14, 2025 Q2 2025 |
1,390,028
shares
|
$2.28 Million
0.45% of portfolio
|
Q2 2025
Added 79.12%
|
|
Bollard Group LLC
Boston, MA |
Aug 13, 2025 Q2 2025 |
1,352,276
shares
|
$2.22 Million
0.04% of portfolio
|
Q2 2025
Reduced 5.05%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
1,143,806
shares
|
$1.88 Million
0.0% of portfolio
|
Q2 2025
Added 1.94%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,006,893
shares
|
$1.65 Million
0.0% of portfolio
|
Q2 2025
Added 147.08%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Aug 12, 2025 Q2 2025 |
1,006,549
shares
|
$1.65 Million
0.0% of portfolio
|
Q2 2025
Added 9.01%
|
|
Aldebaran Capital, LLC
Indianapolis, IN |
Aug 12, 2025 Q2 2025 |
993,698
shares
|
$1.63 Million
1.39% of portfolio
|
Q2 2025
Reduced 1.41%
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Aug 07, 2025 Q2 2025 |
797,134
shares
|
$1.31 Million
0.0% of portfolio
|
Q2 2025
Reduced 7.85%
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
766,255
shares
|
$1.26 Million
0.0% of portfolio
|
Q2 2025
Added 184.76%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
764,300
shares
|
$1.25 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.96%
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
749,660
shares
|
$1.23 Million
0.0% of portfolio
|
Q2 2025
Reduced 8.61%
|